Interestingly, COX2 inhibitors enhance the anti-tumor effects of DC-based vaccines and promote tumor-specific T cell responses in the MMTV-neu autochthonous murine mammary carcinoma model further suggesting an immunologic role for COX2 in cancer (35). Here, PTGS2 is linked to breast carcinoma.